Abtrace co-founder and CEO, Dr. Umar Naeem Ahmad told the media, “Abtrace is part of the paradigm shift: from reactive to proactive care, from late diagnosis to early detection, from healthcare records that just store data to intelligent predictive systems that use it to improve and save lives.

“Our results so far have been hugely encouraging and we’re delighted that these investors have made it possible to expand our reach to help more patients.”

The startup, which was established in 2018 by NHS doctors, has developed an AI tool that can be plugged into the Electronic Health Record (EHR) database to identify which tests or treatments a patient with a long-term health condition needs or might benefit from.

Last week, it was reported that UK HealthCare will offer a third dose of the Pfizer-BioNTech and Moderna Covid-19 vaccines for solid-organ transplant recipients and other immunocompromised individuals. This will be done in accordance with guidance from the FDA and the CDC.

Currently, only immunocompromised individuals who are 18 years or older are eligible for a third-dose booster vaccination. Individuals who have previously received two doses of either of the vaccines are eligible to request the third dose.

The post London-based healthtech Abtrace raises £2.1 mn to enhance tech capabilities appeared first on International Finance.

The letter read, “Covid-19 has infected over 148 million people and killed over three million globally, with hundreds of thousands of new cases and thousands of deaths being reported daily.”

Those senators are Elizabeth Warren, Edward J Markey, Tammy Baldwin, Jeffrey A Merkley, and Christopher Murphy. They further said, “Though Pfizer, Moderna, Johnson & Johnson, and other companies have developed safe and effective Covid-19 vaccines, the uncontrolled spread of coronavirus poses significant risks to global vaccination efforts: as the virus proliferates, it is evolves increasing the risk of a variant developing that renders vaccinations ineffective.”

Recently, Covid-19 cases have surged in India. The country has reported more than 300,000 thousand cases each day for the last two weeks. The senators also noted that India, which produces the Oxford/AstraZeneca Covid-19 vaccine, has so far exported more than 66 million doses globally this year.

“Though wealthier countries, including the US, have successfully secured vaccines and have made significant strides in vaccinating their populations, many middle- and lower-income nations have less access to vaccine doses. A recent study estimates that unequal global vaccine distribution could result in a gross domestic product loss of $1.2 trillion annually for the global economy,” the senators added.

The post US senators call for global access of Pfizer, Moderna Covid-19 vaccines appeared first on International Finance.